SciClone Pharma (SCLN) Posts Mixed Q4 Results
Tweet
Share
E-mailGet Alerts SCLN Hot Sheet
Price: $11.15 --0%
Financial Fact:
Diluted net income per share: 0.19
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Diluted net income per share: 0.19
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN) reported Q4 EPS of $0.08, $0.03 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $23.62 million versus the consensus estimate of $23.59 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
